Sign in

CIK 0001130598

  • Non-accelerated filer
  • Smaller reporting company

Traws Pharma, Inc.

Sign in to watch
Ticker
TRAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-759-3680
Business address
12 PENNS TRAIL, NEWTOWN, PA, 18940
Former names
Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2013-07-30 MEHTA VIREN Director Conversion · Series B Convertible Preferred Stock −5,488 0
2013-07-30 MEHTA VIREN Director Conversion · Series C Convertible Preferred Stock −2,270 0
2013-07-30 MEHTA VIREN Director Conversion · Series D Convertible Preferred Stock −2,296 0
2013-07-30 MEHTA VIREN Director Conversion · Series B Convertible Preferred Stock −1,245 0
2013-07-30 MEHTA VIREN Director Conversion · Series C Convertible Preferred Stock −460 0
2013-07-30 MEHTA VIREN Director Conversion · Series D Convertible Preferred Stock −451 0
2013-07-30 Kumar Ramesh President and CEO Conversion +3,748 246,696
2013-07-30 Kumar Ramesh President and CEO Conversion +17,424 264,120
2013-07-30 Kumar Ramesh President and CEO Conversion +737 264,857
2013-07-30 Kumar Ramesh President and CEO Conversion +1,657 266,514
2013-07-30 Kumar Ramesh President and CEO Conversion +811 267,325
2013-07-30 Kumar Ramesh President and CEO Conversion +385 267,710
2013-07-30 Kumar Ramesh President and CEO Conversion +573 268,283
2013-07-30 Kumar Ramesh President and CEO Conversion +375 268,658
2013-07-30 Kumar Ramesh President and CEO Conversion +75 268,733
2013-07-30 Kumar Ramesh President and CEO Purchase +6,667 $15.00 $100K 275,400
2013-07-30 Kumar Ramesh President and CEO Conversion · Series A Convertible Preferred Stock −4,667 0
2013-07-30 Kumar Ramesh President and CEO Conversion · Series B Convertible Preferred Stock −20,645 0
2013-07-30 Kumar Ramesh President and CEO Conversion · Series C Convertible Preferred Stock −983 0
2013-07-30 Kumar Ramesh President and CEO Conversion · Series D Convertible Preferred Stock −2,209 0

Page 25 of 30 · 590 trades